Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2-Reference-Cited by-同舟云学术

Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2

Published:2023-07 Issue: Volume:122-123 Page:108366
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Wichmann Christian Werner,Burvenich Ingrid Julienne Georgette,Guo Nancy,Rigopoulos Angela,McDonald Alexander,Cao Diana,O'Keefe Graeme Joseph,Gong Sylvia Jie,Gan Hui Kong,Scott Fiona Elizabeth,Pore Nabendu,Coats Steven,Scott Andrew Mark

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference27 articles.

1. Antibody-drug conjugates in cancer therapy;Sievers;Annu Rev Med,2013

2. Discovery and development of MEDI7247, a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2, for treating hematological cancers;Pore;Blood,2018

3. Potential mechanisms for thrombocytopenia development with trastuzumab emtansine (T-DM1);Uppal;Clin Cancer Res,2015

4. ASCT2 and LAT1 contribution to the hallmarks of cancer: from a molecular perspective to clinical translation;Lopes;Cancers (Basel),2021

5. The role of ASCT2 in cancer: a review;Liu;Eur J Pharmacol,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with 89Zr-labelled CI-8993;European Journal of Nuclear Medicine and Molecular Imaging;2024-07-26

2. Comprehensive review of amino acid transporters as therapeutic targets;International Journal of Biological Macromolecules;2024-03